WFDC2 and carcinoma: HE4+ CTCs were also detected in the peripheral blood of HE4 IHC negative patients (Figure 4B), indicating that peripheral HE4+ CTC count might be independent of HE4 expression in the primary carcinoma, and that CTC surface markers might differ compared to the primary site.